News in brief: Ambulatory BP monitoring MBS listing; DOACs have fewer interactions; FFR vs angiography approaches in STEMI

Ambulatory BP monitoring to be Medicare funded The Budget announcement of $40.5 million for Medicare listing of ambulatory blood pressure monitoring (ABPM) has been welcomed by the High Blood Pressure Research Council of Australia. The new MBS item is scheduled to commence on 1 November 2021, and will cover diagnosis of hypertension using ABPM in ...

Already a member?

Login to keep reading.

© 2021 the limbic